Table 1.
Groups and sample sizes investigated in this study.
Group | Genotype | Estradiol | Loading Condition | Sample Size (n) |
---|---|---|---|---|
1 | WT | Placebo | NL | 6 (Histology); 6 (PCR and μCT) |
2 | WT | Estradiol | NL | 6 (Histology); 6 (PCR and μCT) |
3 | WT | Placebo | DOL | 6 (Histology); 6 (PCR and μCT) |
4 | WT | Estradiol | DOL | 6 (Histology); 6 (PCR and μCT) |
5 | ERβKO | Placebo | NL | 6 (Histology); 6 (PCR and μCT) |
6 | ERβKO | Estradiol | NL | 6 (Histology); 6 (PCR and μCT) |
7 | ERβKO | Placebo | DOL | 6 (Histology); 6 (PCR and μCT) |
8 | ERβKO | Estradiol | DOL | 6 (Histology); 6 (PCR and μCT) |